News

Short-sighted: Why the administration’s opioid plan won’t work
The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...
TheHyperHive on MSN4d
Is This Non-Opioid Painkiller the End of the Opioid Crisis?
How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...
American Council on Science and Health2d
Possible New Era in Pain Management: FDA Approves Novel Non-Opioid Analgesic
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
Is this cannabis-based alternative to opioid painkillers the key to treating chronic pain?
More than one in three adults in the UK suffers from chronic pain — just under 28 million people, according to the National Institute for Health and Care Excellence (Nice). But until now, the ...
Nature8d
New approaches to opioid-free pain treatment
On 30 January 2025, the US Food and Drug Administration (FDA) approved the non-opioid medication suzetrigine (JOURNAVX), which was developed by Vertex Pharmaceuticals for moderate to severe acute ...
Want to reduce opioid addiction? Remove roadblocks limiting safer pain meds | Opinion
System that prioritizes opioids over non-addictive alternatives needs fixing, says ophthalmologist and Kansas senator.
Winona Daily News28d
New non-opioid anti-pain pill approved- Healthful Hints
The Food and Drug Administration recently approved a new, non-opioid (non-narcotic) prescription pill, suzetrigine (SUE-zeh-TRY-gene). It will be sold under the brand name Journavx (JOUR-nah-vix ...
Physician's Weekly23d
Addressing Acute Pain & Related Challenges: Will Recent FDA Approval of a Novel Non-Opioid Analgesic Be a Game Changer?
FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve clinical outcomes and QOL.